Evidence map›Paper›PMID 31982872›Full record

ReviewDevelopmental neuroscience2019

Regulation of Central Nervous System Development by Class I Histone Deacetylases.

Santosh R D'Mello

Open access · bronzeAbstract readReview
In one paragraph

Review in Developmental neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Basic Epigenetic Mechanisms.Sub-cellular biochemistry · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Histone deacetylase-3: Friend and foe of the brain.Experimental biology and medicine (Maywood, N.J.) · 2020
    Review
  15. Review
  16. Self and the Brain. The Immune Metaphor.Frontiers in psychiatry · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Santosh R D'MelloDepartment of Biological Sciences, Southern Methodist University, Dallas, Texas, USA, dmello9218@gmail.com.
Southern Methodist University · US

Funding

Signaling Pathways Regulating Neuronal SurvivalR01NS040408 · NINDS · UNIVERSITY OF TEXAS DALLAS · PI D'MELLO, SANTOSH R · 2002 to 2018
$4.8M
FoxP1 as a therapeutic target for Huntington's diseaseR01NS102192 · NINDS · SOUTHERN METHODIST UNIVERSITY · PI ORR, WILLIAM C. · 2018 to 2019
$652k
Understanding MeCP2 duplication syndromeR01NS104508 · NINDS · SOUTHERN METHODIST UNIVERSITY · PI D'MELLO, SANTOSH R · 2018 to 2019
$624k
NINDS NIH HHS R01 NS040408NINDS NIH HHS R01 NS102192NINDS NIH HHS R01 NS104508
6 · The paper itself

Abstract

Neurodevelopment is a highly complex process composed of several carefully regulated events starting from the proliferation of neuroepithelial cells and culminating with and refining of neural networks and synaptic transmission. Improper regulation of any of these neurodevelopmental events often results in severe brain dysfunction. Accumulating evidence indicates that epigenetic modifications of chromatin play a key role in neurodevelopmental regulation. Among these modifications are histone acetylation and deacetylation, which control access of transcription factors to DNA, thereby regulating gene transcription. Histone deacetylation, which restricts access of transcription factor repressing gene transcription, involves the action of members of a family of 18 enzymes, the histone deacetylases (HDAC), which are subdivided in 4 subgroups. This review focuses on the Group 1 HDACs - HDAC 1, 2, 3, and 8. Although much of the evidence for HDAC involvement in neurodevelopment has come from the use of pharmacological inhibitors, because these agents are generally nonselective with regard to their effects on individual members of the HDAC family, this review is limited to evidence garnered from the use of molecular genetic approaches. Our review describes that Class I HDACs play essential roles in all phases of neurodevelopment. Modulation of the activity of individual HDACs could be an important therapeutic approach for neurodevelopmental and psychiatric disorders.

Indexed as

AcetylationAnimalsBrainEpigenesis, GeneticHistone DeacetylasesHumansMental DisordersTranscription FactorsHistone DeacetylasesTranscription FactorsCerebellumConditional knockoutHistone deacetylaseNeocortexNeural progenitor cellsNeurodevelopmentNeurodevelopmental disorders

Identifiers

PMID31982872
PMCPMC7263453
OpenAlexW3002938713

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.